Bernhard Robl

555 total citations
14 papers, 400 citations indexed

About

Bernhard Robl is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Bernhard Robl has authored 14 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Bernhard Robl's work include Sarcoma Diagnosis and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Immunotherapy and Immune Responses (2 papers). Bernhard Robl is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Immunotherapy and Immune Responses (2 papers). Bernhard Robl collaborates with scholars based in Switzerland, Austria and Germany. Bernhard Robl's co-authors include Bruno Fuchs, Sander M. Botter, Beata Bode‐Lesniewska, Wilfred Druml, Walter Born, Marcus Müllner, Markus Wahrmann, Kurt Derfler, Thomas Soliman and Markus Exner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Hepatology.

In The Last Decade

Bernhard Robl

14 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernhard Robl Switzerland 13 139 99 91 85 73 14 400
Bishu Ganguly United States 11 122 0.9× 21 0.2× 39 0.4× 200 2.4× 34 0.5× 17 439
Selene Colon United States 13 165 1.2× 8 0.1× 96 1.1× 134 1.6× 37 0.5× 19 516
Pam Pritzl United States 9 129 0.9× 13 0.1× 49 0.5× 61 0.7× 40 0.5× 9 461
Irmgard Kronberger Austria 8 75 0.5× 13 0.1× 196 2.2× 55 0.6× 92 1.3× 15 427
Alona Merkulova United States 11 180 1.3× 4 0.0× 43 0.5× 48 0.6× 69 0.9× 16 516
Simone Biagini Italy 7 146 1.1× 9 0.1× 21 0.2× 107 1.3× 47 0.6× 11 368
Yinlu Chen United States 6 283 2.0× 6 0.1× 14 0.2× 53 0.6× 44 0.6× 8 390
Bernard Dazey France 12 96 0.7× 5 0.1× 69 0.8× 83 1.0× 39 0.5× 22 484
Balvir Kunar United States 7 243 1.7× 2 0.0× 59 0.6× 95 1.1× 28 0.4× 11 395
Daniel Heudobler Germany 13 188 1.4× 2 0.0× 55 0.6× 70 0.8× 87 1.2× 45 426

Countries citing papers authored by Bernhard Robl

Since Specialization
Citations

This map shows the geographic impact of Bernhard Robl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Robl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Robl more than expected).

Fields of papers citing papers by Bernhard Robl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Robl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Robl. The network helps show where Bernhard Robl may publish in the future.

Co-authorship network of co-authors of Bernhard Robl

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Robl. A scholar is included among the top collaborators of Bernhard Robl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Robl. Bernhard Robl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Schmidt, Ulrike, Thomas Kolbe, Caroline Lassnig, et al.. (2023). Inducible overexpression of a FAM3C/ILEI transgene has pleiotropic effects with shortened life span, liver fibrosis and anemia in mice. PLoS ONE. 18(9). e0286256–e0286256. 2 indexed citations
2.
Königshofer, Philipp, Benedikt Hofer, Ksenia Brusilovskaya, et al.. (2021). Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies. Hepatology. 75(3). 610–622. 30 indexed citations
3.
Thiem, Ursula, Bernhard Robl, Ewa Wątorek, et al.. (2020). The effect of phosphate binder therapy with sucroferric oxyhydroxide on calcification propensity in chronic haemodialysis patients: a randomized, controlled, crossover trial. Clinical Kidney Journal. 14(2). 631–638. 14 indexed citations
4.
Robl, Bernhard, et al.. (2017). Evaluation of F8-TNF-α in Models of Early and Progressive Metastatic Osteosarcoma. Translational Oncology. 10(3). 419–430. 12 indexed citations
5.
Robl, Bernhard, et al.. (2016). Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model. Journal of Experimental & Clinical Cancer Research. 35(1). 113–113. 13 indexed citations
6.
Arlt, Matthias, Marcus Thelen, Ana Gvozdenovic, et al.. (2016). Altered CXCL12 expression reveals a dual role of CXCR4 in osteosarcoma primary tumor growth and metastasis. Journal of Cancer Research and Clinical Oncology. 142(8). 1739–1750. 14 indexed citations
7.
Botter, Sander M., Bernhard Robl, Susanna Gräfe, et al.. (2016). Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models. International Journal of Cancer. 140(7). 1680–1692. 36 indexed citations
8.
Robl, Bernhard, Chantal Pauli, Sander M. Botter, Beata Bode‐Lesniewska, & Bruno Fuchs. (2015). Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy. BMC Cancer. 15(1). 379–379. 32 indexed citations
9.
Boro, Aleksandar, Matthias Arlt, Bernhard Robl, et al.. (2015). Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma. PubMed. 7(3). 640–53. 16 indexed citations
10.
Betz, Michael, et al.. (2014). ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2. BMC Cancer. 14(1). 559–559. 16 indexed citations
11.
Jentzsch, Thorsten, et al.. (2014). Expression of MSH2 and MSH6 on a tissue microarray in patients with osteosarcoma.. PubMed. 34(12). 6961–72. 17 indexed citations
12.
Jentzsch, Thorsten, et al.. (2014). Worse prognosis of osteosarcoma patients expressing IGF-1 on a tissue microarray. PubMed. 34(8). 3881–9. 24 indexed citations
13.
Robl, Bernhard, et al.. (2012). Reconstitution of the central and peripheral nervous system during salamander tail regeneration. Proceedings of the National Academy of Sciences. 109(34). E2258–66. 64 indexed citations
14.
Wahrmann, Markus, Heinz Regele, Markus Exner, et al.. (2006). Immunoadsorption in Severe C4d-Positive Acute Kidney Allograft Rejection: A Randomized Controlled Trial. American Journal of Transplantation. 7(1). 117–121. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026